First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

The primary aim of the present study was to evaluate whether maintenance therapy with capecitabine or hormone replacement therapy (HRT) results in improved progression-free survival (PFS) in metastatic breast cancer (MBC) patients who had previously achieved disease control with first-line docetaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: LIANG, XU, YAN, YING, WANG, LINA, SONG, GUOHONG, DI, LIJUN, JIANG, HANFANG, WANG, CHAOYING, LI, HUIPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301516/
https://www.ncbi.nlm.nih.gov/pubmed/25621076
http://dx.doi.org/10.3892/ol.2014.2787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301516/
https://www.ncbi.nlm.nih.gov/pubmed/25621076
http://dx.doi.org/10.3892/ol.2014.2787

Ejemplares similares